This prospective study, published in the *Journal of Preventive Alzheimer's Disease*, introduces promising speech-based digital biomarkers for the early stratification of Alzheimer's disease (AD) and frontotemporal degeneration (FTD). By analyzing speech patterns, researchers aim to differentiate between these neurodegenerative conditions at their earliest stages, even before definitive clinical diagnosis. The research highlights the potential of accessible technology to identify subtle linguistic changes associated with specific etiologies. This could pave the way for earlier and more accurate diagnostic pathways, potentially leading to more targeted interventions for individuals with AD and FTD, underscoring the growing importance of digital tools in neurological assessment.
Original publication date: 2026 Apr 17
Read Full Research Article →